- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$5.45 BnMarket Estimate, 2026
$5.85 BnMarket Forecast, 2034
$10.28 BnCAGR, 2026–2034
7.3%North America Defibrillators Market Size, Growth, Trends & Forecast (2026–2034)
The North America Defibrillators Market size was valued at USD 5.45 billion in 2025, is anticipated to reach USD 5.85 billion in 2026, and is projected to scale up to USD 10.28 billion by 2034, registering a compound annual growth rate (CAGR) of 7.30% during the forecast period from 2026 to 2034. Driven by a growing elderly population, rising incidences of cardiac disorders, and continuous technological advancements in life-saving medical devices, the market continues to expand steadily across the region.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 5.45 Billion
- 2026 Current Valuation: USD 5.85 Billion
- 2034 Forecast Valuation: USD 10.28 Billion
- Compound Annual Growth Rate (CAGR): 7.30% (2026–2034)
- Dominant Product Type: Implantable & External Defibrillators (accounting for major sales volume, led by Automated External Defibrillators and ICDs)
- Fastest-Growing Product Type: Automated External Defibrillators (AEDs) & Wearable Cardioverter Defibrillators (WCDs) (propelled by public access programs and portable emergency needs)
- Dominant End User Segment: Hospitals (holding a major share due to intensive cardiac care and surgical treatments)
- Fastest-Growing End User Segment: Public Access Market & Home Care (expanding rapidly due to growing awareness and the need for early defibrillation outside clinical settings)
- Dominant Country: United States (retaining a leading regional share backed by numerous medical device corporations and widespread public AED deployment)
Core Market Drivers
- Aging Population & Cardiac Risks: Increasing geriatric demographic combined with a rising prevalence of cardiovascular and cardiac arrest disorders.
- Early Defibrillation Awareness: Growing emphasis on rapid response times (within 3–5 minutes of collapse) to increase survival rates by up to 50–70 percent.
Primary Market Restraints & Challenges
- Clinical Complications: Risks of skin burns, myocardial necrosis, potential product failures, and patient fear associated with surgical implantation.
- High Costs & Knowledge Gaps: Rising device costs alongside a lack of public awareness and adequate defibrillator coverage in certain localized areas.
North America Defibrillators Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Product | Implantable Cardioverter Defibrillators & External AEDs (dominant clinical and public units) | Automated External Defibrillators (AEDs) & Wearable Cardioverter Defibrillators (fastest-growing due to portability and public placement) |
| By End User | Hospitals (leading volume consumer for acute cardiac care) | Public Access Market & Home Care (fastest-growing segments driven by community safety initiatives) |
| By Country | The United States (dominant regional market with thousands of deployed public AEDs) | Canada & Regional Public Access Sectors (expanding through targeted sudden cardiac arrest survival programs) |
Major Industry Players Profiled
Key enterprises shaping the competitive North American defibrillators market include Medtronic PLC, St. Jude Medical, Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Koninklijke Philips N.V., ZOLL Medical Corporation, Cardiac Science Corporation, Physio-Control, Inc., and Nihon Kohden Corporation.
Download Free Sample Report
North America Defibrillators Market Size
The North America Defibrillators Market is projected to grow from USD 5.45 billion in 2025 to USD 5.85 billion in 2026 and reach USD 10.28 billion by 2034, registering a CAGR of 7.30% during the forecast period from 2026 to 2034.
The growing elderly population primarily drives the market for defibrillators in North America, an increase in the prevalence of cardiac disorders, increase in the rapid innovations and technical developments with life-saving devices.
People opting for early defibrillation as the sooner someone is defibrillated after a cardiac arrest, the higher the chances of survival. It is basically due to the flow of oxygenated blood around the body, which decreases and finally ceases if the heart stops pumping efficiently. When vital organs are deprived of oxygen-rich blood, they begin to die.
Increase the survival rates by 50-70 percent if the defibrillator is used within 3-5 minutes of collapsing of the patient. Also, an increase in the awareness of the importance of good cardiac health and market players are estimated to further drive the defibrillators market growth in North America.
Due to an increase in risk factors like skin burns, myocardial necrosis, side effects, fear of implantation, spreading of infection with rising in the cost of the medical devices. Also, a rise in the number of product failures, lack of awareness in some areas is estimated to hamper the market growth of the defibrillators.
MARKET SEGMENTATION
This research report on the North American defibrillators market has been segmented and sub-segmented into the following categories.
North America Defibrillators Market - By Product
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Wearable Cardioverter Defibrillator (WCDs)
North America Defibrillators Market - By End User
-
Hospitals
-
Prehospital
- Public Access market
- Alternate Care Market
- Home
North America Defibrillators Market - By Country
-
The United States
-
Canada
- Rest of North America
Regionally, North America was leading the global defibrillator market in 2023. Defibrillators are of different types: manual external defibrillator, manual internal defibrillator, automated external defibrillator (AED), implanted cardioverter-defibrillator (ICD), and wearable cardiac defibrillator are all examples of these devices accounting for 35.0 percent of sales. This is due to the presence of numerous firms in the US. There are presently about 3.2 million AEDs in public locations. Still, more than 30 million AEDs are needed to ensure adequate coverage and increase the national SCA survival rate, which is currently less than 8%.
Each year up to 45,000 Canadians experiences sudden cardiac arrest, according to the Heart and Stroke Foundation of Canada. It's critical to get cardiopulmonary resuscitation (CPR) and defibrillation as soon as possible following a cardiac arrest (1 to 3 minutes;) therefore, automated external defibrillators are used as they are small and portable and have 75 percent of surviving chances.
KEY MARKET PLAYERS
A few of the prominent companies leading the North America defibrillators market profiled in the report are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan).